AsOf

Recorded or changed on this day 2026-11-08

45,251–45,300 of 46,525 claims, by entity. Everything on 2026-11-08 →

superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 981,354,000 United States dollar
Vertex Pharmaceuticals total equity: 981,354,000 United States dollar, claim clm_E3F59624DB5A · ended · superseded by clm_26C5F13E4AFA · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · 1,151,100,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: 1,151,100,000 United States dollar, claim clm_E417E8C56F51 · ended · superseded by clm_7EF8A5505C22 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 6,261,958,000 United States dollar
Vertex Pharmaceuticals total assets: 6,261,958,000 United States dollar, claim clm_E43D77EF5B44 · ended · superseded by clm_3ECBB5B268CD · 2 sources (2 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 178,987,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 178,987,000 United States dollar, claim clm_E49939D6DEDB · ended · superseded by clm_72E202E696DB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 455,973,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 455,973,000 United States…, claim clm_E4E066FF8D42 · ended · superseded by clm_DC884CD97A0D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 555,948,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 555,948,000 United States…, claim clm_E4FC8BA4267A · ended · superseded by clm_5AE1EF5CC196 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 23,917,400,000 United States dollar
Vertex Pharmaceuticals total assets: 23,917,400,000 United States dollar, claim clm_E4FE15D6C00A · ended · superseded by clm_91183B1230B5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 436,886,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 436,886,000 United States dollar, claim clm_E50A47FF19A4 · ended · superseded by clm_FCBF93D0B813 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 132,132,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 132,132,000 United States…, claim clm_E5A0F7F2EB85 · ended · superseded by clm_D2BF7F6D2E9B · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Vertex Pharmaceuticals · registrant name · VERTEX PHARMACEUTICALS INC / MA
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · 1,126,700,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: 1,126,700,000 United States dollar, claim clm_E6727C1C16C9 · ended · superseded by clm_4D9C12DA102E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 12,221,686,000 United States dollar
Vertex Pharmaceuticals total assets: 12,221,686,000 United States dollar, claim clm_E7CFB5DF9247 · ended · superseded by clm_90424EB08D26 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · operating income · 113,820,000 United States dollar
Vertex Pharmaceuticals operating income: 113,820,000 United States dollar, claim clm_E814D4173C5E · ended · superseded by clm_4F9C4EE9CB90 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · 1,045,400,000 United States dollar
Vertex Pharmaceuticals quarterly net income: 1,045,400,000 United States dollar, claim clm_E844FD7AD190 · ended · superseded by clm_EDC8CDDAA243 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Vertex Pharmaceuticals · SEC CIK · 0000875320
Vertex Pharmaceuticals SEC CIK: 0000875320, claim clm_E8D76EDFB1A2 · valid · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 210,335,993 shares
Vertex Pharmaceuticals shares outstanding: 210,335,993 shares, claim clm_E8ED2497AD7B · ended · superseded by clm_78F55C9D6D48 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Vertex Pharmaceuticals · total assets · 32,736,300,000 United States dollar
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · -38,841,000 United States dollar
Vertex Pharmaceuticals quarterly net income: -38,841,000 United States dollar, claim clm_E8FAE6590B2B · ended · superseded by clm_EB70297A6910 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 246,391,955 shares
Vertex Pharmaceuticals shares outstanding: 246,391,955 shares, claim clm_E922A99A9EA6 · ended · superseded by clm_184409A3DE47 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 248,033,389 shares
Vertex Pharmaceuticals shares outstanding: 248,033,389 shares, claim clm_E95980D51DAA · ended · superseded by clm_56628A376B7F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 253,805,417 shares
Vertex Pharmaceuticals shares outstanding: 253,805,417 shares, claim clm_EA3BCAE7F8D0 · ended · superseded by clm_10753153913F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · operating income · 4,307,400,000 United States dollar
Vertex Pharmaceuticals operating income: 4,307,400,000 United States dollar, claim clm_EA4DD24E67F5 · ended · superseded by clm_EDF03CE5BDB7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · net income · 263,484,000 United States dollar
Vertex Pharmaceuticals net income: 263,484,000 United States dollar, claim clm_EAA313C25D3D · ended · superseded by clm_D3A2B88BD1F9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · 720,224,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: 720,224,000 United States dollar, claim clm_EB1B0B642262 · ended · superseded by clm_FE5D60C65052 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 233,756,871 shares
Vertex Pharmaceuticals shares outstanding: 233,756,871 shares, claim clm_EB4B38E18AF2 · ended · superseded by clm_E2A186C9E37B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · 247,756,000 United States dollar
Vertex Pharmaceuticals quarterly net income: 247,756,000 United States dollar, claim clm_EB70297A6910 · ended · superseded by clm_DAC478AD397E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 664,879,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 664,879,000 United States dollar, claim clm_ECB58BC2FBDB · ended · superseded by clm_1EF267F21DD6 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · -176,096,000 United States dollar
Vertex Pharmaceuticals quarterly net income: -176,096,000 United States dollar, claim clm_ECF62E043F01 · ended · superseded by clm_46C52FB158CE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 1,515,107,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 1,515,107,000 United States dollar, claim clm_ED12A2E330B4 · ended · superseded by clm_EE20986F8F62 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · -102,952,000 United States dollar
Vertex Pharmaceuticals quarterly net income: -102,952,000 United States dollar, claim clm_ED246483C6AB · ended · superseded by clm_6AE5A6A85AD2 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · revenue · 1,410,626,000 United States dollar
Vertex Pharmaceuticals revenue: 1,410,626,000 United States dollar, claim clm_EDAEC8A3D536 · ended · superseded by clm_1A11D785AD34 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 418,305,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 418,305,000 United States dollar, claim clm_EDB18FEAB098 · ended · superseded by clm_8B3F25617388 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · 646,300,000 United States dollar
Vertex Pharmaceuticals quarterly net income: 646,300,000 United States dollar, claim clm_EDC8CDDAA243 · ended · superseded by clm_C2590A2F1C6C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · operating income · 3,832,000,000 United States dollar
Vertex Pharmaceuticals operating income: 3,832,000,000 United States dollar, claim clm_EDF03CE5BDB7 · ended · superseded by clm_33A4466539E6 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 1,524,485,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 1,524,485,000 United States dollar, claim clm_EE20986F8F62 · ended · superseded by clm_D38659C12AE8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · -159,899,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: -159,899,000 United States dollar, claim clm_EF4EBE9A383C · ended · superseded by clm_D1B891CE165A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · research and development · 1,416,476,000 United States dollar
Vertex Pharmaceuticals research and development: 1,416,476,000 United States dollar, claim clm_EF7099311C58 · ended · superseded by clm_4875DCC74B8B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 2,196,200,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 2,196,200,000 United States dollar, claim clm_F084A45C1F3A · ended · superseded by clm_A07370340B6C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · -170,060,000 United States dollar
Vertex Pharmaceuticals quarterly net income: -170,060,000 United States dollar, claim clm_F0EB4C4B4423 · ended · superseded by clm_64459540A52F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 221,400,864 shares
Vertex Pharmaceuticals shares outstanding: 221,400,864 shares, claim clm_F2071C89A470 · ended · superseded by clm_BEFDB3212DCF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 215,807,482 shares
Vertex Pharmaceuticals shares outstanding: 215,807,482 shares, claim clm_F20A5D8DC03B · ended · superseded by clm_70D8F6354992 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 243,752,247 shares
Vertex Pharmaceuticals shares outstanding: 243,752,247 shares, claim clm_F2E292BAD47A · ended · superseded by clm_74711F790F20 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 2,650,134,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 2,650,134,000 United States dollar, claim clm_F36C4149DAE9 · ended · superseded by clm_AA625CEFE3E2 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · net income · 2,342,100,000 United States dollar
Vertex Pharmaceuticals net income: 2,342,100,000 United States dollar, claim clm_F3A2B9FC81F1 · ended · superseded by clm_1B7C3640D846 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 22,533,200,000 United States dollar
Vertex Pharmaceuticals total assets: 22,533,200,000 United States dollar, claim clm_F4271585E734 · ended · superseded by clm_AE9230AA7FE8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 939,967,000 United States dollar
Vertex Pharmaceuticals total equity: 939,967,000 United States dollar, claim clm_F45B3CB0C752 · ended · superseded by clm_AB61E3D00C03 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 544,135,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 544,135,000 United States dollar, claim clm_F514C594F662 · ended · superseded by clm_933F26C8B388 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 257,149,588 shares
Vertex Pharmaceuticals shares outstanding: 257,149,588 shares, claim clm_F6BD01886FBB · ended · superseded by clm_B0DC25435A02 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 559,133,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 559,133,000 United States dollar, claim clm_F77D600A24ED · ended · superseded by clm_0B1A1540D1B7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · -57,543,000 United States dollar
Vertex Pharmaceuticals quarterly net income: -57,543,000 United States dollar, claim clm_F8030CD50108 · ended · superseded by clm_34EFC0C950B9 · 1 source (1 primary) · conf 0.95

What the statuses mean